The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Manu Sebastiana, Harsh Batrab, Monika Lamba [...]
In this episode of the Digital Pathology Podcast, I sit down with Danielle Brown, the General Manager at Charles River Laboratories and an expert in toxicologic pathology. Danielle and I explore the evolving role of image analysis in preclinical studies, diving into how this technology enhances—rather than replaces—the expertise of pathologists. We discuss the [...]
Zero-footprint web portals and AI-enhanced workflows reduce screening bottlenecks for an AKT-Pathway clinical trial In Brief Oncology research trials require patients but enrollment can be a major limiter. 40% of oncology trials fail due to under-enrollment and 80% do not meet enrollment timelines Imagenomix addresses the enrollment challenge: Imagenomix’s Predict AI model for rapid mutation prediction from [...]
The university hospital TUM Klinikum Rechts der Isar (TUM Klinikum) in Germany expands its enterprise imaging solution from international medical imaging IT and cybersecurity company Sectra (STO: SECT B) by adding the modules for pathology and ophthalmology. This will provide their clinicians with tools for enhanced efficiency, helping them enhance diagnostic speed, as well as foster collaboration within [...]
According to Mordor Intelligence, the digital pathology market is valued at USD 2.01 billion in 2026, and is projected to surpass USD 3.2 billion by 2031, growing at a CAGR of 9.90% during the forecast period (2026-2031). The market is supported by rising cancer incidence, growing demand for faster and more accurate diagnostics, and increasing use of artificial intelligence and machine learning in pathology interpretation. Digital [...]
Recent industry survey shows nearly one-third of US health systems now pay for commercial AI licenses Artificial intelligence is rapidly reshaping the healthcare industry, and more Americans are turning to AI tools for medical guidance. OpenAI says about 40 million users worldwide now use ChatGPT daily for health-related questions. The company recently launched ChatGPT Health, a [...]
by Christos Evangelou, MSc, PhD – Medical Writer and Editor When CyTOF technology was first developed for analyzing cells in suspension, critics consistently pointed out the loss of tissue context as a key limitation. That criticism became the driving force behind one of the most transformative technologies in spatial biology. CODEX, developed in Nolan’s Stanford laboratory, now allows researchers to analyze more [...]
AIVIS, a leading AI-based digital pathology company, presented new research results at ESMO Asia 2025 demonstrating that AI assistance can significantly enhance consistency and diagnostic accuracy in HER2 immunohistochemistry (IHC) interpretation for breast cancer. The abstract showed that AI-assisted reading improves inter-observer agreement among pathologists and strengthens consistency in identifying patients with HER2-low and HER2-ultralow expression. [...]
From Jan. 23–25, the elea team will attend the 105th Annual Meeting of the Texas Society of Pathologists (TSP) in Plano, Texas. TSP is a key forum for discussing how pathology workflows are evolving in practice, from reporting and documentation to digital and AI-supported processes. Being present allows elea to contribute our perspective from building and [...]
Following its qualification by the EMA earlier this year, PathAI’s AIM-MASH AI Assist* has now been qualified by the FDA for use in phase 2 and 3 MASH clinical trials to aid pathologist review of liver biopsies for the purposes of trial enrollment and primary/secondary endpoint histology assessment for accelerated approval. This is the first AI-powered pathology [...]
